RxDoctor Payments Data

Deirdre Marshall

Plastic and Reconstructive Surgery · Miami, FLNPI 1508880733

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,420 of the $14,022 with a category attached, or 88.6%. 20 manufacturers reported payments, led by AbbVie at 33.2% of the total. Reporting peaked in 2023 at $3,534 and has fallen 79.0% since, to $743 in 2025.

$14,022in general payments, 2019–2025

Across 165 payments — averaging $84.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Musculoskeletal Transplant Foundation Inc.$3K
  • Mentor Worldwide LLC$2K
  • Merz North America, Inc.$1K
  • TELA Bio, Inc.$886
  • Axogen$392
  • plus $1K from 14 others

What the payments were for

  • Travel & lodging$1,60211%
  • Food & beverage$12,42089%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,022 in reported general payments places this provider in the 80th percentile of 235 plastic and reconstructive surgery providers in Florida.

See all plastic and reconstructive surgery providers in Florida

Medicare billing

Part B allowed, 2024
$43,075
Medicare patients
25
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin68$819
Acetaminophen-CodeineAcetaminophen With Codeine52$376
Cyclobenzaprine Hcl39$191
Gabapentin61$156
Mupirocin13$92
Levofloxacin13$49

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →